1609 related articles for article (PubMed ID: 15149507)
21. Transforming growth factor-beta receptor II is preferentially expressed in the companion layer of the human anagen hair follicle.
Sowden HM; Karoo RO; Tobin DJ
Br J Dermatol; 2007 Jul; 157(1):161-4. PubMed ID: 17578439
[TBL] [Abstract][Full Text] [Related]
22. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
23. Hair follicle structures targeted by antibodies in patients with alopecia areata.
Tobin DJ; Hann SK; Song MS; Bystryn JC
Arch Dermatol; 1997 Jan; 133(1):57-61. PubMed ID: 9006373
[TBL] [Abstract][Full Text] [Related]
24. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
Tokuyama W; Mikami T; Masuzawa M; Okayasu I
Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
[TBL] [Abstract][Full Text] [Related]
25. Induction of cellular immunity against hair follicle melanocyte causes alopecia.
Nagai H; Oniki S; Oka M; Horikawa T; Nishigori C
Arch Dermatol Res; 2006 Aug; 298(3):131-4. PubMed ID: 16786344
[TBL] [Abstract][Full Text] [Related]
26. Expression of hair follicle stem cells detected by cytokeratin 15 stain: implications for pathogenesis of the scarring process in cutaneous lupus erythematosus.
Al-Refu K; Edward S; Ingham E; Goodfield M
Br J Dermatol; 2009 Jun; 160(6):1188-96. PubMed ID: 19298282
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
28. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.
Faaij CM; Lankester AC; Spierings E; Hoogeboom M; Bowman EP; Bierings M; Révész T; Egeler RM; van Tol MJ; Annels NE
Br J Haematol; 2006 Jun; 133(5):538-49. PubMed ID: 16681643
[TBL] [Abstract][Full Text] [Related]
29. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
30. Influence of interleukin-1alpha on androgen receptor expression and cytokine secretion by cultured human dermal papilla cells.
Boivin WA; Jiang H; Utting OB; Hunt DW
Exp Dermatol; 2006 Oct; 15(10):784-93. PubMed ID: 16984260
[TBL] [Abstract][Full Text] [Related]
31. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.
Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819
[TBL] [Abstract][Full Text] [Related]
32. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
[TBL] [Abstract][Full Text] [Related]
33. Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers.
Hunter N; Shaker O; Marei N
J Dermatolog Treat; 2011 Feb; 22(1):2-10. PubMed ID: 20524872
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
J Autoimmun; 2004 Nov; 23(3):241-56. PubMed ID: 15501395
[TBL] [Abstract][Full Text] [Related]
35. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.
Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I
Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575
[TBL] [Abstract][Full Text] [Related]
36. CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.
Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Stramazzotti D; Morichetti D; Bernardini ML; Mannello B; Fabris G; Offidani A
Br J Dermatol; 2007 Dec; 157(6):1155-60. PubMed ID: 17916208
[TBL] [Abstract][Full Text] [Related]
37. CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model.
Chen L; Lin SX; Agha-Majzoub R; Overbergh L; Mathieu C; Chan LS
Int Immunol; 2006 Aug; 18(8):1233-42. PubMed ID: 16735375
[TBL] [Abstract][Full Text] [Related]
38. Predictive model for immunotherapy of alopecia areata with diphencyprone.
Wiseman MC; Shapiro J; MacDonald N; Lui H
Arch Dermatol; 2001 Aug; 137(8):1063-8. PubMed ID: 11493099
[TBL] [Abstract][Full Text] [Related]
39. Diphencyprone in the treatment of alopecia areata.
Happle R; Hausen BM; Wiesner-Menzel L
Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
[TBL] [Abstract][Full Text] [Related]
40. Hair follicle stem cell marker nestin expression in regenerating hair follicles of patients with alopecia areata.
Amoh Y; Maejima H; Niiyama S; Mii S; Hamada Y; Saito N; Katsuoka K
Eur J Dermatol; 2011; 21(2):209-12. PubMed ID: 21524985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
